Hyoscine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Hyoscine market is segmented By Type (Hyoscine Butyl Bromide, Hyoscine Hydrobromide), Mode of Administration (Oral, Patches, Injections), and Geography.

Hyoscine Market Snapshot

Hyoscine Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4 %
Hyoscine Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Hyoscine Market is expected to register a CAGR of 4% during the forecast period attributing to effective medicine for motion sickness leading to a rise in consumer awareness towards hyoscine. Moreover, Motion sickness such as nausea, vomiting may cause by an increase in travelling which further led to the adoption of hyoscine medicines. For instance, According to National Library of Medicine (NIH) in 2018, Motion sickness is the common condition characterized by travelling or motion and frequency is one in three people are susceptible to this condition which leads to the rising demand of hyoscine. Furthermore, growth in a number of surgeries supplement is also one of the factors boosting the hyoscine market attributing to use in surgeries for controlling and decreasing saliva content and gastric acid, to slow gut motility and prevent vomiting. Moreover, the rise in usage of transdermal hyoscine patches in surgeries & post-operative recovery and a rise in emphasis on community healthcare in developing countries is expected to provide a lucrative opportunity in developing countries. However, stringent regulation related to the manufacturing and marketing of hyoscine products may hamper the market to a certain extent.

Scope of the Report

Hyoscine is an effective medicine for motion sickness and used to treat postoperative nausea, gastrointestinal spasm, and vomiting. This medicine belongs to the antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.

By Type
Hyoscine Butylbromide
Hyoscine Hydrobromide
By Mode of Administration
Oral
Patches
Injections
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral Hyoscine is Expected to Hold a Major Market Share in the Hyoscine Market

Oral hyoscine is expected to contribute the largest segment attributing to ease of administration, easy availability and wide preference in abdominal muscle cramp and treating motion sickness. Oral tablets compared to patches and injection will not need prescriptions and can easily available in pharmacies, leading to low health care costs and further drive the oral segment. Moreover increased patient pool and increase in travelling population is leading to a high demand of hyoscine and propel the growth of oral hyoscine market.

Hyoscine Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Hyoscine market owing to many market players operating in manufacturing the medicines, growth in number of surgeries supplements, growing healthcare concern, increasing healthcare expenditure and presence of well-established healthcare infrastructure.

Hyoscine Market Growth

Competitive Landscape

The market studied is moderately competitive and there are several international and local companies operating in this market. Some of the companies which are in the market are Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation., Alchem International Pvt. Ltd, Guangzhou HanFang Pharmaceutical, MYUNGMOON PHARM CO., LTD., and Perrigo.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Consumer Awareness Towards Hyoscine

      2. 4.2.2 Increase in Travelling

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Hyoscine Butylbromide

      2. 5.1.2 Hyoscine Hydrobromide

    2. 5.2 By Mode of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Patches

      3. 5.2.3 Injections

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Caleb Pharmaceuticals, Inc

      2. 6.1.2 Baxter International

      3. 6.1.3 Alkaloids Corporation.

      4. 6.1.4 Alchem International Pvt. Ltd

      5. 6.1.5 Guangzhou HanFang Pharmaceutical

      6. 6.1.6 MYUNGMOON PHARM CO.,LTD.

      7. 6.1.7 Perrigo

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hyoscine Market market is studied from 2018 - 2026.

The Hyoscine Market is growing at a CAGR of 4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation, Alchem International Pvt. Ltd, Guangzhou HanFang Pharmaceutical are the major companies operating in Hyoscine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!